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m: MACULAR RETINAL DYSTROPHY, DEAFNESS AND 
DIABETES MELJJTUS , ASSOCIATED WlTH A MUTATION 
OF MITOCHONDRIAL DNA @RNA let’(3243)) 
a: P Ms.&t 1, PJ Guillausseau 1, B Vislettes 2, H Gin 3, 
A Gtimsldi 4, V Paquis 6, F Orsini 2, A Leys 5 Deprutments of 
Ophthalmology and Diabetolo~ ,,lPstis Lsriboiii&e, 2Mssseille. 
3Bordeaux. Parts La PitiC, Ltege, 6~abcratory of Cellular 
Neurobiology, Nice. France. 
a:To repcst the association of macular dystrophy with 
matemslly inherited diabetes mellitus, deafness and “pigmentary 
due to a mutation of mitochondrial DNA (tRNA 
M&~&we examined 8 diabetic probands with this mutation to 
precise the characteris& of the tetinopathy associated with this 
mutation. 
R&D: These probands belonged to 6 different families; six of 
them had deafness. The 8 patients had a bilateral macular 
dystrophy, called “pattern dystrophy”, chsracterised by radiate 
pattern of pigmented lesions surrounding the macula, and 
atrophic changes in the posterior pole. The peri hery of the 
~lesicms and fundus was unaffected. The extent of pigmen 
atrophic changes diiered with cases, but the 3 probsnds of the 
sane family had the same aspect of the fundus. Vii acuity wss 
normal in 7 patients, and slightly decreased in cute. 
Electroretinogrsm wss nomtsl, that definitively eliminates the 
diasnosis of tetinitis &ntentosa. - . 
Conclusron: the ret&l lesion associated with maternally 
inherited diabetes mellitus due to a mutation of mitochondrial 
DNA (tRNA (leu (3243)) is a macular pattern dystrophy, whose 
visual prognosis is relatively good This aspect could be s good 
marker of the m”tati0”. 
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Zermatt Macular Dystrophy: a new autosomal dominant 
phenotype and exclusion of known macular genes. 
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Cantonal Universitaire, Lausanne, Switzerland. 3 The University of Iowa 
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Purpose: Age related macular degeneration remains the leading cause of 
blindness in the Western countries in adults over 65 years of age. For a 
subgroup of familial macular dystrophies such as Best disease, North 
Carolina macular dystrophy, pattern dystrophies and 5orsby’s fundus 
dystrophy the genetic defect has been mapped cr klentified. The purpose of 
this peper is to describe a yet unrecognized autoSomal dominant 
progressive macular dystrophy, named “Zennatt Macular Dystrophy” after 
the origin of the affected family, and to procede with a mutational analysis 
of the known macular genes. 
Methods: The family was ascertained through the macular clinic at Jules 
Gonin Eye Hospital in i-ausanne. After informed consent, a comprehensive 
eye examination, including fluorescein angiogram was performed on every 
family member at risk of carrying the disease gene. Blond was drawn for 
DNA extraction and mutational analysis of known macular genes was 
performed. 
R&&The four generation Swiss family originated from Zermatt (Valais 
reaion). Of a total of 51 individuals at risk. 23 were affected. The earlv 
ph&o&pic changes consisted of central pignwntary alterations during _ 
addescence followed by multiple druaenokl deposits in the course of the 
second and third decade. Early symptoms include dyschmmatopsia and 
Drogressive perifoveal scotomas, ultimatelv leading to the loss of central 
is& in the ‘fourth decade due to extensive geogmihical atrophy. The 
transmission of the disease is autcsomal dominant and Denetrance awaared 
to be canplete. 
No mutation was identified in the known macular genes. 
conclusions: Zermatt macular dystrophy appsanto be a new macular 
phenotype for which the genetic defect remains unidentified. A linkage 
analysis of this family will be the next approach. 
TITLE: "KINETIC B-SCAN ULTRASONOGRAPHY OF THE POSTERIOR 
VITREQREl'INAL INTERFACE IN EYES WITH AGE RELATED MACULAR HOLE<" 
AUlY0RS: CAPEANS C. SANTOS L. LORENZO J. COPENA W. SUAREZ A. 
PACHFCO P. RAF%0 E. and SANCHEZ SALoR M. 
Department of Ophthalrolqy and INGO, University of Santiago 
ds cOmposteia (SPAIN). 
PURPOSE: The etiopatholcgy of age related macular holes remairr; 
uncertain. There's general agreement that macular vitreoreti- 
nal interface plays a determinant role in the pathcqenesis. 
In this paper we will investigate which is this role by the 
ultrasoncqraphy point of view. 
METHODS: By using kinetic B-scan ultrasoncgraphy we evaluate 
the posterior vitreoretinal interface of 30 eyes haviq macu- 
lx holes, without retinal detachmsnt, which were previously 
diagnosed by bionicroscopy. 
RESULTS: A complete posterior vitreous detachment was confir- 
med in 6 patients, an operculae or pseudo-operculae could be 
visualiced in 10 patients. Incomplete posterior vitreous sema- 
ration with vitreous still attached to the macular area was- 
demonstrated in 25 patients. Mscular thickness was evident in 
22 patients, while fovea1 "depression" could be confirmed in 
18 eyes. 
coNcLUSIONS: Sam hypothesis are based on the active contrac- 
tion of the posterior vitreous cortex over the macula. Vi- 
treous induced retraction cd" produce fovea1 detachment as 
the first step in the development of a ocular hole, cases 
which show incomplete vitreous separation may have vitreous 
cortex still adherent to the macula what provokes continues 
or intermittent traction on the tw.cu1.s. Eccqraphically detec- 
tabs& opercula or pseudo-opercula, my contribute to better 
distinguish the evolutive stage of the macular hole. 
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IDENTIFICATION OF GLYCOSAMINOGLYCANS IN 
AGERELATED MACULAR DEPOSITS 
KLIFFEN M.‘HUUMANS J.G.M.2 MOOY C.M.‘,’ LUIDER T.M.’ 
KERKVLIET S.’ AND DE JONG P.T.V.M.’ 
’ Institute of Ophthalmology, ’ Clinical Genetics, and s Pathology, 
Erasmus University, Rotterdam, The Netherlands. 
Purnose, To investigate the presence and localisstion of 
glycosaminoglycans (GAGS) in human maculae with age-related 
maculopathy (ARM). 
Methods, ARM was defined as presence of basal laminar deposit (BLD) 
and/or drusen in the macula on histology. The presence and localisation 
of GAGS in 25 pamftin-embedded human maculae were examined 
immunohistochemicslly with monoclonal antibodies specific for 
chondroitin+sulfate, heparan sulfate proteoglycan, and keratan sulfate. 
Furthermore, macular homogenates were separately analysed with tw+ 
dimensional electmphoresis on cellulose acetate membranes. Quantitative 
analysis of GAGS was done snectronhotometticallv. 
&&&, Immunohistochemic~ly, afi BLD stained’positive for 
chondroitin-4-sulfate, and fccsllv wsitive for hemwan sulfate 
proteoglycan. Drusen did not s&n with any of the monoclonal 
antibodies. With two-dimensional electrophoresis it was demonstrated 
that all macular extracts contained chondroitin sulfate. Heparan sulfate 
was only expressed in maculae with ARM. The total amount of GAGS in 
macular extracts with BLD was significantly higher than in maculae 
without BLD @=O.OOl). There was no relation between the amount of 
GAGS and drusen. 
Conclusions. Signiflcsnt differences in amount and composition of 
GAGS, between maculae with ARM and controls, were demonstrated 
with these techniques. Furthermore, chondroitin-4-sulfate and heparan 
sulfate proteoglycsn were detected immunohistochemically in BLD, but 
not in drusen. 
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